Trials / Completed
CompletedNCT00702858
Trial of Blue Citrus Compared to Placebo in Patients Receiving Aromatase Inhibitor Therapy for Estrogen Receptor Positive Post-Menopausal Breast Cancer
Pilot, Single Center Randomized Controlled, Double-Blind, Cross Over, Intent to Treat Trial of Blue Citrus to Placebo in Those Breast Cancer Patients Receiving Aromatase Inhibitor Therapy
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- Legacy Health System · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This purpose of this study is to determine if the herbal compound, Blue Citrus, decreases joint and bone pain associated with Aromotase Inhibitor therapy (AIT). Another purpose of the study is to find out if Blue Citrus improves how you feel while taking AIT and if your quality of life improves.
Detailed description
Post-menopausal women currently on AIT for breast cancer treatment who self-report musculoskeletal side effects related to AIT to their physicians.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Blue Citrus | Five 700 mg Capsules three times a day to equal 15 capsules per day for 3 months |
| DRUG | Placebo | Five Placebo capsules three times a day to equal 15 capsules per day for 3 months |
Timeline
- Start date
- 2008-04-01
- Primary completion
- 2011-06-01
- Completion
- 2011-06-01
- First posted
- 2008-06-20
- Last updated
- 2013-08-28
Source: ClinicalTrials.gov record NCT00702858. Inclusion in this directory is not an endorsement.